Dean Maeda
0000-0002-9304-6846
3 papers found
Refreshing results…
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Missing publications? Search for publications with a matching author name.